Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
02/2014
02/26/2014CN103601732A Nitrogen-substituted podophyllotoxin derivative with anti-tumor activity and preparation method and use thereof
02/26/2014CN103601730A Crown ether ring-shaped quinazoline nitrogen mustard compound, and preparation method and application thereof in tumor treatment
02/26/2014CN103601722A Novel antineoplastic compounds
02/26/2014CN103601720A Solid salt forms of a pyrrole substituted 2-indolinone
02/26/2014CN103601719A 2, 2'-bipyridine-6, 6'-diformyl-quinolyl-2-amine derivative, and preparation method and applications thereof
02/26/2014CN103601707A Sesquiterpene nitrobenzoate compounds, preparation method thereof and applications thereof in anti-tumor medicine preparation
02/26/2014CN103601697A 4-tertiary butyl-5-(2-nitroethyl)-2-acylamino thiazole and preparation method and application thereof
02/26/2014CN103601684A 5-arylselenobenzimidazole compound and application thereof
02/26/2014CN103601681A 3,5-pyrazoldione derivative containing exocyclic double bond structure unit and preparation method and application thereof
02/26/2014CN103601676A Synthetic method for high-enantioselectivity N-acetyl-2-substitued-2, 3-dihydro-4-quinolinone compounds
02/26/2014CN103601673A Fluorinated derivatives of 3-hydroxypyridin-4-ones
02/26/2014CN103601670A Piplartine analogue, and preparation method and application thereof
02/26/2014CN103601649A Novel compound
02/26/2014CN103601641A Glaucocalyxin derivatives and application thereof in preparation of antitumor drugs
02/26/2014CN103601621A Schisandrin and pharmaceutical application thereof
02/26/2014CN103599549A SiRNA (Small interfering Ribonucleic Acid)/anti-cancer drug combined transferring composite supporter and preparation method and application thereof
02/26/2014CN103599548A Paclitaxel polymer bonding drug and preparation method thereof
02/26/2014CN103599528A Method for preparing human dendritic cell vaccine
02/26/2014CN103599493A Preparation method and application of liver-restoring tablet
02/26/2014CN103599453A Traditional Chinese medicine for treating gastric cancer of spleen-stomach deficiency and preparation method thereof
02/26/2014CN103599418A Traditional Chinese medicine composition for treating laryngeal tumor
02/26/2014CN103599337A 大蒜皂苷脂质体及其制备方法 Garlic saponin liposomes and its preparation method
02/26/2014CN103599292A Preparation method and application of angelica sinensis and radix paeoniae alba liujun pill
02/26/2014CN103599286A Traditional Chinese medicine composition for treating fibroid
02/26/2014CN103599271A Traditional Chinese medicine for treating hysteromyoma
02/26/2014CN103599237A Traditional Chinese medicine for treating gastric cancer of stasis in stomach collateral type and preparation method thereof
02/26/2014CN103599236A Traditional Chinese medicine for treating liver-stomach disharmony stomach cancer and preparation method thereof
02/26/2014CN103599217A Preparation method and application of cough and asthma pill
02/26/2014CN103599189A Zhenqi Fuzheng (Chinese character) injection preparation and preparation method thereof
02/26/2014CN103599167A Medicament for treating lung cancer
02/26/2014CN103599163A Medicine composition with anticancer effect
02/26/2014CN103599151A Red ginseng for injection and processing method thereof
02/26/2014CN103599144A Preparation method for effective part of valerianajatamansi epoxy iridoid ester
02/26/2014CN103599138A Cordyceps militaris extract lozenge
02/26/2014CN103599137A Health food containing plurality of trace nutrient elements
02/26/2014CN103599133A Method for preparing medical toad cortex preparation
02/26/2014CN103599132A Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
02/26/2014CN103599127A Application of ruthenium complex in antitumor drug preparation
02/26/2014CN103599125A Anti-radiation and assistant anti-tumor drug and application
02/26/2014CN103599122A Application of timosaponin AIII in anemarrhena to preparation of antitumor drugs
02/26/2014CN103599111A Combined drug for treating pancreatic cancer
02/26/2014CN103599110A Application of cucurbitacin B and analogs thereof in preparation of drugs for treating endometrial cancer
02/26/2014CN103599107A Novel applications of bis(alpha-furancarboxylato)oxovanadium as anticancer medicine
02/26/2014CN103599093A Novel anti-HPV (Human Papillomavirus) medicinal preparation and application
02/26/2014CN103599090A Multi-layer drug sustain-release nano fiber membrane and preparation method thereof
02/26/2014CN103599083A Levo-oxiracetam slow-release tablet and preparation method thereof
02/26/2014CN103599079A Lobaplatin pharmaceutical composition for injection and preparation method thereof
02/26/2014CN103599078A Preparing method of compound brucea javanicaseed oil liposome freeze-dried powder
02/26/2014CN103599073A Method for preparing targeted anti-cancer medicament supported PLGA (poly(lactic-co-glycolic) acid) microparticles
02/26/2014CN103599071A Preparation method of polyinosinic-polycytidylic acid dry powder
02/26/2014CN103599070A Preparation method of temperature and fluorescence probe of lipidosome loaded with gold nanocluster and anti-cancer drug
02/26/2014CN103599069A Targeted lipidosome decorated by pH sensitive polypeptide
02/26/2014CN103599068A Drug-loaded nano-micelle, anti-cancer medicament and preparation method thereof
02/26/2014CN103027953B Extractive containing total meroterpenoid of psidium guajave dialdehyde, and preparation method and application thereof
02/26/2014CN102988748B Preparation method and application of yin tonifying and blood sugar reducing tablet
02/26/2014CN102988723B Preparation method and application of traditional Chinese medicine
02/26/2014CN102949346B Protein medicine-carrying nano particle synthesis method
02/26/2014CN102732524B Use of histidine-rich glycoprotein (HRG)-like lampetra japonica Lj-RGD3 all RGD deletion mutant Lj-112 in antitumor drug
02/26/2014CN102725283B Compounds and compositions as protein kinase inhibitors
02/26/2014CN102666530B Imatinib dichloroacetate and anti-cancer agent comprising the same
02/26/2014CN102659593B Shikonin benzene oxygen carboxylic acid ester derivative and synthesizing method and application thereof
02/26/2014CN102657597B Biodegradable super-molecular hydrogel loaded with antitumor medicament and preparation method thereof
02/26/2014CN102641245B Chitosan-chitosan derivative nanosphere for loading indissoluble medicament, preparation method of nanosphere, and application of nanosphere serving as oral prepration
02/26/2014CN102613356B Aquilaria agallocha leaf tea, as well as preparation and application thereof
02/26/2014CN102558187B Tetrahydroporphin compound and preparation method and application thereof
02/26/2014CN102526146B Medicament composition containing ginsenoside and cantharidin and application of medicament composition
02/26/2014CN102503951B Garcinia derivative and preparation method and medicinal application thereof
02/26/2014CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases
02/26/2014CN102417479B STAT3 small molecular selective inhibitor and preparation method and application thereof
02/26/2014CN102344489B Modified sodium iodine symporter protein and application thereof
02/26/2014CN102321635B Preparation method for human papillomaviral empty capsid particles, and products thereof
02/26/2014CN102267888B Chalcone derivative preparation method
02/26/2014CN102174044B Tetomilast polymorphs
02/26/2014CN102099352B STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
02/26/2014CN101966292B Sugarless Chinese medicinal oral liquid and preparation method thereof
02/26/2014CN101932592B Antitumoral compounds
02/26/2014CN101671301B Heterocyclic substituent acardite derivate and application thereof
02/26/2014CN101518528B Application of carbocyanine dye near infrared fluorescent compound
02/26/2014CN101472888B Optical pure chromocor derivate for treating proliferative lesion and preparation method thereof
02/26/2014CN101003573B Human antibodies that bind human tnfalpha
02/25/2014US8658703 Aqueous suspension preparations
02/25/2014US8658668 PI3 kinase/mTOR dual inhibitor
02/25/2014US8658654 Receptor-type kinase modulators and methods of use
02/25/2014US8658634 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
02/25/2014US8658623 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
02/25/2014US8658610 Replication-competent anti-cancer vectors
02/25/2014US8658607 Immunostimulatory G, U-containing oligoribonucleotides
02/25/2014US8658591 Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
02/25/2014US8658433 Dye compounds as photoactive agents
02/25/2014US8658170 Combination therapy with MDM2 and EFGR inhibitors
02/25/2014US8658158 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
02/25/2014CA2788707C Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
02/25/2014CA2748814C Methods for treating vascular leak syndrome
02/25/2014CA2747954C Phosphonate compounds
02/25/2014CA2636993C Pyrimidine derivatives used as pi-3 kinase inhibitors
02/25/2014CA2636217C Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
02/25/2014CA2630410C 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
02/25/2014CA2621127C Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms
02/25/2014CA2544949C Antagonist anti-cd40 monoclonal antibodies and methods for their use
02/25/2014CA2505325C Stabilized single domain antibodies
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 2211